For the year ending 2025-12-31, ALHC had $142,994K increase in cash & cash equivalents over the period. $113,146K in free cash flow.
| Cash Flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Payment-in-kind interest | - | 0 | - | - |
| Net loss | -978 | -128,071 | - | - |
| Gain on sale of property and equipment | - | 9 | - | - |
| Provision for credit loss | 833 | 123 | - | - |
| (gain) loss on right of use assets | 0 | -143 | - | - |
| Gain on sale of property and equipment | 72 | 0 | - | - |
| Depreciation and amortization | 30,482 | 27,062 | - | - |
| Amortization-debt issuance costs | 1,761 | 1,293 | - | - |
| Amortization-investment discount | 1,298 | 2,579 | - | - |
| Amortization of payment-in-kind interest | - | 0 | - | - |
| Equity-based compensation | 62,082 | 71,132 | - | - |
| Non-cash lease expense | 1,609 | 1,764 | - | - |
| Loss on extinguishment of debt | 0 | -3,020 | - | - |
| Accounts receivable | 100,106 | 34,278 | - | - |
| Prepaid expenses and other current assets | 57,059 | -7,887 | - | - |
| Other assets | 50 | -60 | - | - |
| Medical expenses payable | 184,781 | 84,389 | - | - |
| Accounts payable and accrued expenses | 10,364 | -1,460 | - | - |
| Accrued compensation | 9,082 | 5,819 | - | - |
| Lease liabilities | -1,504 | -1,525 | - | - |
| Net cash provided by (used in) operating activities | 139,927 | 34,770 | - | - |
| Purchase of investments | 65,633 | 82,200 | - | - |
| Sale of property and equipment | 75 | 14 | - | - |
| Maturities of investments | 76,300 | 162,795 | - | - |
| Sale of business | 1,065 | - | - | - |
| Purchase of business, net of cash received | - | 0 | - | - |
| Acquisition of property and equipment, net | 26,781 | 41,418 | - | - |
| Net cash provided by (used in) investing activities | -14,974 | 39,191 | - | - |
| Proceeds from long-term debt | 0 | 380,000 | - | - |
| Debt issuance costs | 26 | 8,792 | - | - |
| Repurchase of noncontrolling interest | - | 0 | - | - |
| Repayment of long-term debt | 0 | 215,000 | - | - |
| Payment of employment taxes related to release of restricted stock | 0 | 350 | - | - |
| Proceeds from exercise of stock options | 18,067 | 155 | - | - |
| Contributions from noncontrolling interest holders | 0 | 15 | - | - |
| Net cash provided by financing activities | 18,041 | 156,028 | - | - |
| Restricted cash in other assets | - | - | 2,050 | 1,750 |
| Net increase (decrease) in cash | 142,994 | 229,989 | - | - |
| Cash and cash equivalents | - | - | 202,904 | 409,549 |
| Cash, cash equivalents and restricted cash at beginning of period | 434,943 | - | - | - |
| Cash, cash equivalents and restricted cash at end of period | 577,937 | - | 204,954 | 411,299 |
Alignment Healthcare, Inc. (ALHC)
Alignment Healthcare, Inc. (ALHC)